Willmer–Hulme, A.
Mayo Clinic
From the Mount Sinai School of Medicine (Dr. Brin)New York, NY; University of Southern California (Dr. Lew), Los Angeles, CA; Mayo Clinic Scottsdale (Dr. Adler), Scottsdale, AZ; Rush Presbyterian–St. Luke’s Medical Center (Dr. Comella), Chicago, IL; Albany
Citations 2
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia
Brin, Mitchell F. , Lew, Mark, Comella, Cynthia , O’Brien, C., Murray, JC, Wallace, J D, Willmer–Hulme, A., Köller, M., Adler, Charles H. , Factor, Stewart Alan , Jankovic, Joseph J.
Neurology | May 13, 2012 | Volume: 53 | Issue: 7 | Pages: 1431-1431
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS
Sheremata, William, Vollmer, Timothy R. , Stone, Lael A., Willmer–Hulme, A., Köller, M.
Neurology | May 13, 2012 | Volume: 52 | Issue: 5 | Pages: 1072-1072